Filing Details

Accession Number:
0001735276-18-000039
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-07-27 16:07:17
Reporting Period:
2018-07-25
Accepted Time:
2018-07-27 16:07:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1178670 Alnylam Pharmaceuticals Inc. ALNY Pharmaceutical Preparations (2834) 770602661
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1180432 John Maraganore 300 Third Street
Cambridge MA 02142
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-07-25 50,000 $21.35 201,297 No 4 M Direct
Common Stock Disposition 2018-07-25 2,000 $102.51 199,297 No 4 S Direct
Common Stock Disposition 2018-07-25 3,847 $103.69 195,450 No 4 S Direct
Common Stock Disposition 2018-07-25 7,758 $104.83 187,692 No 4 S Direct
Common Stock Disposition 2018-07-25 34,995 $105.83 152,697 No 4 S Direct
Common Stock Disposition 2018-07-25 1,400 $106.25 151,297 No 4 S Direct
Common Stock Acquisiton 2018-04-16 30 $0.00 2,990 No 5 J Indirect by Managed Account
Common Stock Acquisiton 2018-07-10 31 $0.00 3,021 No 5 J Indirect by Managed Account
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 5 J Indirect by Managed Account
No 5 J Indirect by Managed Account
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2018-07-25 50,000 $0.00 50,000 $21.35
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
98,636 2018-12-08 No 4 M Direct
Footnotes
  1. All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 16, 2018. The 50,000 options exercised and sold by the reporting person were due to expire on December 8, 2018.
  2. Sale prices ranged from $101.99 to $102.94.
  3. Sale prices ranged from $103.10 to $104.04.
  4. Sale prices ranged from $104.17 to $105.15.
  5. Sale prices ranged from $105.17 to $106.13.
  6. Sale prices ranged from $106.18 to $106.33.
  7. Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
  8. The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.